Translational Science for School Nursing and School Health Services

J. Cowell
{"title":"Translational Science for School Nursing and School Health Services","authors":"J. Cowell","doi":"10.1177/1059840516634395","DOIUrl":null,"url":null,"abstract":"Over 10 years ago, Dr. Elias Zerhouni, at the National Institutes of Health (NIH), challenged the biomedical researchers in the United States to translate their innovations to practice, thus advancing the nation’s health (Zerhouni, 2005). While there had been strategies for dissemination of innovations for years, this challenge created a focus at NIH to shorten the gap in time from discoveries to practice. Since that announcement by Dr. Zerhouni, the National Center for Advancing Translational Science has been established with funding mechanisms to promote tested innovations in the community (https://ncats.nih.gov/). Historically, biomedical research in laboratories leads to important discoveries about disease. The findings from laboratory studies are then tested in the clinical setting. There can be four phases of trials: Phase 1—initial safety study with a small sample; Phase 2—a test of effectiveness and additional safety study with larger sample; Phase 3— clinical trial that is double blinded, that is, the investigator nor patient know if they are receiving the experimental treatment. The sample size for Phase 3 trial is large, hundreds to thousands of participants. Phase 4—studies are conducted after the treatment is widely disseminated to determine the effects on diverse populations and to study long-term effects (https:// www.nlm.nih.gov/services/ctphases.html). The adoption of tested interventions into general practice takes decades. Translational research introduces new methods that accelerate the processes of biomedical research by the use of collaborative links that provide feedback. Thus, two new stages of research design shorten the phases of the traditional clinical trials. The new stages include the continuous refinement and evaluation of innovations across diverse populations. Additionally, feedback from the community is introduced from the initial creation of the innovation, the design to intervention testing (Grady, 2010). The use of community advisory groups has become common place at all stages of research, as translational science tenets become common place. Grady highlighted the importance of research that is multidisciplinary, that is, coordinated among scientists of different disciplines. She highlighted the fact that interdisciplinary research shows cooperation of scientists in addressing issue crossing boundaries. Finally, Grady promoted transdisciplinary efforts with collaborative projects that go beyond any one discipline (Grady, 2010). The core of the evidence-based practice movement and translational science movement has been to bring evidence to clinical practice (Pearson, Jordan, & Munn, 2012). Implications for Authors","PeriodicalId":77407,"journal":{"name":"The Academic nurse : the journal of the Columbia University School of Nursing","volume":"2 1","pages":"79 - 80"},"PeriodicalIF":0.0000,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Academic nurse : the journal of the Columbia University School of Nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1059840516634395","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Over 10 years ago, Dr. Elias Zerhouni, at the National Institutes of Health (NIH), challenged the biomedical researchers in the United States to translate their innovations to practice, thus advancing the nation’s health (Zerhouni, 2005). While there had been strategies for dissemination of innovations for years, this challenge created a focus at NIH to shorten the gap in time from discoveries to practice. Since that announcement by Dr. Zerhouni, the National Center for Advancing Translational Science has been established with funding mechanisms to promote tested innovations in the community (https://ncats.nih.gov/). Historically, biomedical research in laboratories leads to important discoveries about disease. The findings from laboratory studies are then tested in the clinical setting. There can be four phases of trials: Phase 1—initial safety study with a small sample; Phase 2—a test of effectiveness and additional safety study with larger sample; Phase 3— clinical trial that is double blinded, that is, the investigator nor patient know if they are receiving the experimental treatment. The sample size for Phase 3 trial is large, hundreds to thousands of participants. Phase 4—studies are conducted after the treatment is widely disseminated to determine the effects on diverse populations and to study long-term effects (https:// www.nlm.nih.gov/services/ctphases.html). The adoption of tested interventions into general practice takes decades. Translational research introduces new methods that accelerate the processes of biomedical research by the use of collaborative links that provide feedback. Thus, two new stages of research design shorten the phases of the traditional clinical trials. The new stages include the continuous refinement and evaluation of innovations across diverse populations. Additionally, feedback from the community is introduced from the initial creation of the innovation, the design to intervention testing (Grady, 2010). The use of community advisory groups has become common place at all stages of research, as translational science tenets become common place. Grady highlighted the importance of research that is multidisciplinary, that is, coordinated among scientists of different disciplines. She highlighted the fact that interdisciplinary research shows cooperation of scientists in addressing issue crossing boundaries. Finally, Grady promoted transdisciplinary efforts with collaborative projects that go beyond any one discipline (Grady, 2010). The core of the evidence-based practice movement and translational science movement has been to bring evidence to clinical practice (Pearson, Jordan, & Munn, 2012). Implications for Authors
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
学校护理和学校卫生服务的转化科学
10多年前,美国国立卫生研究院的Elias Zerhouni博士要求美国的生物医学研究人员将其创新成果转化为实践,从而促进国家健康(Zerhouni, 2005年)。虽然多年来一直有传播创新的策略,但这一挑战使NIH关注缩短从发现到实践的时间差距。自Zerhouni博士宣布这一消息以来,已经建立了国家促进转化科学中心,并建立了资助机制,以促进社区中经过测试的创新(https://ncats.nih.gov/)。从历史上看,实验室的生物医学研究导致了关于疾病的重要发现。然后在临床环境中对实验室研究的结果进行检验。试验可分为四个阶段:第一阶段——小样本的初始安全性研究;第二阶段——有效性测试和更大样本的额外安全性研究;第三阶段-临床试验是双盲的,也就是说,研究者和患者都不知道他们是否正在接受实验性治疗。第三阶段试验的样本量很大,有数百到数千名参与者。第四阶段研究是在治疗广泛传播后进行的,以确定对不同人群的影响并研究长期影响(https:// www.nlm.nih.gov/services/ctphases.html)。将经过检验的干预措施纳入一般实践需要几十年的时间。转化研究引入了新的方法,通过使用提供反馈的协作链接来加速生物医学研究的进程。因此,两个新的研究设计阶段缩短了传统临床试验的阶段。新的阶段包括不断改进和评估不同人群的创新。此外,从创新的最初创造、设计到干预测试,都引入了来自社区的反馈(Grady, 2010)。社区咨询小组的使用在研究的各个阶段已经变得普遍,因为转化科学的原则变得普遍。格雷迪强调了多学科研究的重要性,即不同学科的科学家之间的协调。她强调,跨学科研究表明科学家在解决跨界问题方面的合作。最后,Grady通过超越任何一个学科的合作项目促进了跨学科的努力(Grady, 2010)。循证实践运动和转化科学运动的核心是将证据带到临床实践中(Pearson, Jordan, & Munn, 2012)。对作者的启示
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Journal of School Nursing Reviewer Recognition Shine a Light on School Nurses CORRIGENDUM to “U.S. School Nursing Job Analysis” The Journal of School Nursing Reviewer Recognition A Person-Centred Approach When Encountering Students With Recurrent Pain: School Nurses’ Experiences
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1